IRCT20170608034390N6已完成2 期
Evaluating the Effect of Cabergoline on insulin resistance and anthropometric parameters in patients with Impaired fasting glucose and/or Impaired glucose tolerance, a randomized, blinded clinical trial.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients with Impaired Fasting Glucose and/or Impaired Glucose Tolerance
- •Adults (18-65 years)
排除标准
- •Severe hepatic failure (Child-Pugh scores of 10 or higher)
- •History of pulmonary, pericardial, cardiac valvular, or retroperitoneal fibrotic disorders
- •Hypersensitivity to ergot derivatives
- •Uncontrolled hypertension
- •Pregnant Women
- •Lactating Women
- •Major psychiatric disorders
- •Patients who are receiving medications which affect prolactin secretion
- •Bulimia or/and anorexia nervosa
研究者
相似试验
招募中
3 期
The effect of Cabergoline on blood glucose control in type 2 diabetic patientsIRCT20100314003565N9Tabriz University of Medical Sciences50
已完成
3 期
Treatment of uterine myoma.fibromyoma of uterus.Leiomyoma of uterusfibromyoma of uterusIRCT201403092624N12Vice chancellor for research ,Iran University of Medical Sciences.50
招募中
2 期
Effect of Cabergoline on biochemical and anthropometric parameters of patient with Impaired Glucose metabolism (Impaired Fasting Glucose/Impaired Glucose Tolerance)Metabolic and Endocrine - Metabolic disordersPrediabetesACTRN12613001121752Shahid Beheshti University of Medical Sciences70
Unknown
3 期
Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM PatientsDiabetesNCT03313661Sherief Abd-Elsalam60
尚未招募
Unknown
To study the benefits of addition of Cabergoline to Metformin in women with PCOSCTRI/2024/08/071776il